ArticleBlood cancer journal2026

Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk AML: a multicenter TROPHY study.

Wenxuan Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.